Iranian Red Crescent Medical Journal

Published by: Kowsar

The Overestimation of Vancomycin-Associated Nephrotoxicity: The Effect of Rhabdomyolysis and Nephrotoxicants at a Referral Poison Center, Tehran, Iran

Simin Dokht Shoaei 1 , Mohammad Sistanizad 2 , Naser Mozafari 3 , Tahereh Alinia 4 and Haleh Talaie 5 , *
Authors Information
1 Clinical Research and Development Center, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Plastic Surgery Department, 15 Khordad Hospitals, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Students’ Research Office, Epidemiology Department, Health Faculty, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
5 Toxicological Research Center, Department of Clinical Toxicology, Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: October 2016, 18 (10); e59070
  • Published Online: October 2, 2016
  • Article Type: Research Article
  • Received: June 13, 2016
  • Revised: September 20, 2016
  • Accepted: September 20, 2016
  • DOI: 10.5812/ircmj.39969

To Cite: Shoaei S D, Sistanizad M, Mozafari N, Alinia T, Talaie H. The Overestimation of Vancomycin-Associated Nephrotoxicity: The Effect of Rhabdomyolysis and Nephrotoxicants at a Referral Poison Center, Tehran, Iran, Iran Red Crescent Med J. 2016 ; 18(10):e59070. doi: 10.5812/ircmj.39969.

Copyright © 2016, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011; 52(3): 18-55[DOI][PubMed]
  • 2. Burnham JP, Burnham CD, Warren DK, Kollef MH. Impact of time to appropriate therapy on mortality in patients with vancomycin-intermediate staphylococcus aureus infection. Antimicrob Agents Chem. 2016; 60(9): 5546-53
  • 3. van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis. 2012; 54(6): 755-71[DOI][PubMed]
  • 4. Fullmer A, McCue D, Feng C. Retrospective review of vancomycin-induced nephrotoxicity in patients with leukemia. J Oncol Pharm Pract. 2014; 20(6): 403-8[DOI][PubMed]
  • 5. van Hal SJ, Paterson DL, Lodise TP. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother. 2013; 57(2): 734-44[DOI][PubMed]
  • 6. Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol. 2012; 68(9): 1243-55[DOI][PubMed]
  • 7. Elyasi S, Khalili H, Hatamkhani S, Dashti-Khavidaki S. Prevention of vancomycin induced nephrotoxicity: a review of preclinical data. Eur J Clin Pharmacol. 2013; 69(4): 747-54[DOI][PubMed]
  • 8. Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008; 52(4): 1330-6[DOI][PubMed]
  • 9. Eswarappa M, Gireesh MS, Ravi V, Kumar D, Dev G. Spectrum of acute kidney injury in critically ill patients: A single center study from South India. Indian J Nephrol. 2014; 24(5): 280-5[DOI][PubMed]
  • 10. Piccinni P, Cruz DN, Gramaticopolo S, Garzotto F, Dal Santo M, Aneloni G, et al. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol. 2011; 77(11): 1072-83[PubMed]
  • 11. Zimmermann AE, Katona BG, Plaisance KI. Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia. Pharmacotherapy. 1995; 15(1): 85-91[PubMed]
  • 12. Minejima E, Choi J, Beringer P, Lou M, Tse E, Wong-Beringer A. Applying new diagnostic criteria for acute kidney injury to facilitate early identification of nephrotoxicity in vancomycin-treated patients. Antimicrob Agents Chemother. 2011; 55(7): 3278-83[DOI][PubMed]
  • 13. Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009; 49(3): 325-7[DOI][PubMed]
  • 14. Rybak M, Lomaestro B, Rotschafer JC, Moellering RJ, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009; 66(1): 82-98[DOI][PubMed]
  • 15. Hassanian-Moghaddam H, Zamani N, Rahimi M, Shadnia S, Pajoumand A, Sarjami S. Acute adult and adolescent poisoning in Tehran, Iran; the epidemiologic trend between 2006 and 2011. Arch Iran Med. 2014; 17(8): 534-8[PubMed]
  • 16. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative W. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8(4)-12[DOI][PubMed]
  • 17. Pickering JW, Endre ZH. Back-calculating baseline creatinine with MDRD misclassifies acute kidney injury in the intensive care unit. Clin J Am Soc Nephrol. 2010; 5(7): 1165-73[DOI][PubMed]
  • 18. Kouchek M, Asghari R, Mahdavinejad A, Salimi A, Barari B, Seyedrazi P, et al. Comparative study between teicoplanin and vancomycin in methicillin-resistant staphylococcus aureus (mrsa) infectious of toxicological intensive care unit (ticu) patients-tehran iran. Life Sci J. 2014; 11(3s): 83-90
  • 19. Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis. 2009; 49(4): 507-14[DOI][PubMed]
  • 20. Cimino MA, Rotstein C, Slaughter RL, Emrich LJ. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. Am J Med. 1987; 83(6): 1091-7
  • 21. Elting LS, Rubenstein EB, Kurtin D, Rolston K, Fangtang J, Martin C, et al. Mississippi mud in the 1990s. Cancer. 1998; 83(12): 2597-607
  • 22. Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, et al. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther. 2012; 34(1): 149-57[DOI][PubMed]
  • 23. Matson KL, Shaffer CL, Beck GL, Simonsen KA. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study. Pharmacotherapy. 2015; 35(3): 337-43[DOI][PubMed]
  • 24. Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther. 2007; 29(6): 1107-15[DOI][PubMed]
  • 25. Prabaker KK, Tran TP, Pratummas T, Goetz MB, Graber CJ. Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans. J Hosp Med. 2012; 7(2): 91-7[DOI][PubMed]
  • 26. Ackerman BH, Guilday RE, Reigart CL, Patton ML, Haith LR. Evaluation of the relationship between elevated vancomycin trough concentrations and increased efficacy and/or toxicity. J Burn Care Res. 2013; 34(1): 1-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments